Skip to main content
2022 Annual Clinical Assembly (ACA) Main banner
Final Program


ACA Program Book
Back
Video

Cardiothoracic Surgery

General Vascular Surgery

Surgeons approach to TAVR

Thursday, September 15, 2022
4:30 PM – 5:00 PM East Coast USA Time
Location: JW Grand Ballroom 3
CE: .5
Reference 1: AATS/ACC/ASE/SCAI/STS Expert Consensus for Valvular Heart Disease3

1 Nishimura RA, et al. Circulation. 2014;129:2440-2492.
2 Nishimura RA, et al. Circulation. 2017;135:e1159-e1195.
3 Nishimura RA, et al. J Am Coll Cardiol. 2019;73:2609-2635.

Reference 2: Aortic Stenosis and Coronary Artery Disease: Cost of Transcatheter vs Surgical Management
Sri Harsha Patlolla 1, Hartzell V Schaff 2, Joseph A Dearani 1, John M Stulak 1, Juan A Crestanello 1, Kevin L Greason 1
Affiliations expand
PMID: 34560043 DOI: 10.1016/j.athoracsur.2021.08.028
Reference 3: Aortic Stenosis and Coronary Artery Disease: Cost of Transcatheter vs Surgical Management
Sri Harsha Patlolla 1, Hartzell V Schaff 2, Joseph A Dearani 1, John M Stulak 1, Juan A Crestanello 1, Kevin L Greason 1
Affiliations expand
PMID: 34560043 DOI: 10.1016/j.athoracsur.2021.08.028

    Non-Member Speaker(s)

  • Brendan Dewan, MD FACS

    Cardiothoracic Surgeon
    Cardiothoracic and Vascular Surgeons

    Disclosure(s): No financial relationships to disclose

    Slides
Disclosure(s):
Brendan Dewan, MD FACS: No financial relationships to disclose

Learning Objectives:

  1. Understand the evolution of TAVR therapy
  2. Understand the differences between the two commercially available TAVR valves
  3. Review recent data regarding: -Alternative access -The small annulus -TAVR explantation
  4. Understand when to consider SAVR rather than TAVR